Achieve Life Sciences Inc (NASDAQ: ACHV) kicked off on Friday, down -5.30% from the previous trading day, before settling in for the closing price of $2.64. Over the past 52 weeks, ACHV has traded in a range of $1.84-$5.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 50.01%. While this was happening, its average annual earnings per share was recorded 5.97%. With a float of $43.28 million, this company’s outstanding shares have now reached $49.69 million.
The extent of productivity of a business whose workforce counts for 25 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Achieve Life Sciences Inc (ACHV) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Achieve Life Sciences Inc is 15.32%, while institutional ownership is 45.25%. The most recent insider transaction that took place on Mar 17 ’25, was worth 28,887. In this transaction Chief Financial Officer of this company bought 10,000 shares at a rate of $2.89, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Chieve Executive Officer bought 10,000 for $2.86, making the entire transaction worth $28,598. This insider now owns 60,876 shares in total.
Achieve Life Sciences Inc (ACHV) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.36 earnings per share (EPS), lower than consensus estimate (set at -0.29) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.97% per share during the next fiscal year.
Achieve Life Sciences Inc (NASDAQ: ACHV) Trading Performance Indicators
Take a look at Achieve Life Sciences Inc’s (ACHV) current performance indicators. Last quarter, stock had a quick ratio of 6.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.95 in one year’s time.
Technical Analysis of Achieve Life Sciences Inc (ACHV)
The latest stats from [Achieve Life Sciences Inc, ACHV] show that its last 5-days average volume of 0.69 million was superior to 0.51 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.84%.
During the past 100 days, Achieve Life Sciences Inc’s (ACHV) raw stochastic average was set at 26.83%, which indicates a significant increase from 6.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was lower than the 0.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.94, while its 200-day Moving Average is $3.27.
